MX2020005572A - Método para reducir ototoxicidad en pacientes pediátricos que reciben quimioterapia basada en platino. - Google Patents

Método para reducir ototoxicidad en pacientes pediátricos que reciben quimioterapia basada en platino.

Info

Publication number
MX2020005572A
MX2020005572A MX2020005572A MX2020005572A MX2020005572A MX 2020005572 A MX2020005572 A MX 2020005572A MX 2020005572 A MX2020005572 A MX 2020005572A MX 2020005572 A MX2020005572 A MX 2020005572A MX 2020005572 A MX2020005572 A MX 2020005572A
Authority
MX
Mexico
Prior art keywords
patients receiving
ototoxicity
pediatric patients
based chemotherapy
reducing ototoxicity
Prior art date
Application number
MX2020005572A
Other languages
English (en)
Inventor
Edward A Neuwelt
Original Assignee
Univ Oregon Health & Science
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=66633903&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2020005572(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Oregon Health & Science filed Critical Univ Oregon Health & Science
Publication of MX2020005572A publication Critical patent/MX2020005572A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En la presente se describe un método para eliminar o reducir ototoxicidad en pacientes que reciben una quimioterapia basada en platino; en particular, métodos para reducir ototoxicidad en un paciente pediátrico; los métodos descritos en la presente incluyen administrar una cantidad eficaz de tiosulfato de sodio a un paciente que lo necesita para reducir ototoxicidad.
MX2020005572A 2017-11-29 2018-11-28 Método para reducir ototoxicidad en pacientes pediátricos que reciben quimioterapia basada en platino. MX2020005572A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201715826243A 2017-11-29 2017-11-29
PCT/US2018/062750 WO2019108592A2 (en) 2017-11-29 2018-11-28 Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy

Publications (1)

Publication Number Publication Date
MX2020005572A true MX2020005572A (es) 2020-12-10

Family

ID=66633903

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020005572A MX2020005572A (es) 2017-11-29 2018-11-28 Método para reducir ototoxicidad en pacientes pediátricos que reciben quimioterapia basada en platino.

Country Status (13)

Country Link
US (5) US10596190B2 (es)
EP (1) EP3716987A4 (es)
JP (1) JP2021504401A (es)
KR (1) KR20200084050A (es)
CN (1) CN112955157A (es)
AU (1) AU2018374850A1 (es)
BR (1) BR112020010726A2 (es)
CA (1) CA3082838A1 (es)
IL (1) IL274645A (es)
MX (1) MX2020005572A (es)
RU (1) RU2020122083A (es)
SG (1) SG11202004517WA (es)
WO (1) WO2019108592A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7492917B2 (ja) 2018-02-09 2024-05-30 デシベル セラピューティクス インコーポレイテッド 抗白金化学保護剤を含む高張医薬組成物
MX2020013734A (es) 2018-07-03 2021-05-27 Fennec Pharmaceuticals Inc Formulaciones de tiosulfato de sodio anhidro.
US10813947B1 (en) 2019-05-31 2020-10-27 Decibel Therapeutics, Inc. Methods of otoprotection against platinum-based antineoplastic agents
EP3975722A4 (en) * 2019-05-31 2023-02-08 Decibel Therapeutics, Inc. PLATINUM-BASED OTOPROTECTION AGAINST ANTINEOPLASTISKA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001253919B2 (en) 2000-04-26 2006-12-14 Government Of The United States, D/B/A Department Of Veterans Affairs Administration of a thiol-based chemoprotectant compound
US20040062764A1 (en) 2001-08-30 2004-04-01 Neuwelt Edward A Chemoprotectant for gastric toxicity
US20110104257A1 (en) 2008-04-10 2011-05-05 Hayden Michael R Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity
AU2010270605B2 (en) 2009-07-08 2014-07-31 Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals Sodium thiosulfate-containing pharmaceutical compositions

Also Published As

Publication number Publication date
US20200038436A1 (en) 2020-02-06
CN112955157A (zh) 2021-06-11
RU2020122083A (ru) 2022-03-01
JP2021504401A (ja) 2021-02-15
US20230270776A1 (en) 2023-08-31
US20220280560A1 (en) 2022-09-08
US20230390330A1 (en) 2023-12-07
WO2019108592A2 (en) 2019-06-06
US20190160094A1 (en) 2019-05-30
WO2019108592A3 (en) 2019-07-04
SG11202004517WA (en) 2020-06-29
AU2018374850A1 (en) 2020-07-02
US10596190B2 (en) 2020-03-24
EP3716987A2 (en) 2020-10-07
KR20200084050A (ko) 2020-07-09
IL274645A (en) 2020-06-30
EP3716987A4 (en) 2021-09-01
BR112020010726A2 (pt) 2020-11-10
CA3082838A1 (en) 2019-06-06

Similar Documents

Publication Publication Date Title
MX2020005572A (es) Método para reducir ototoxicidad en pacientes pediátricos que reciben quimioterapia basada en platino.
PH12017502154A1 (en) Methods for conditioning patients for t cell therapy
MY186977A (en) Tetrasubstituted alkene compounds and their use
SG10201807070YA (en) Respiratory mask with nasogastric tube path
MX2017014338A (es) Seleccion dirigida de pacientes para el tratamiento con derivados de cortistatina.
MX2016011132A (es) Métodos para tratar una infección cutánea mediante la administración de un antagonista de il-4r.
MX2019002265A (es) Uso de pridopidina para el tratamiento de la disminucion funcional.
MX2015010191A (es) Metodos para tratar infecciones microbianas, incluyendo mastitis.
MX2015015518A (es) Metodos y composiciones para el tratamiento del cancer.
NZ714684A (en) Stable oral solutions for combined api
PH12016502352A1 (en) Pharmaceutical composition
MX2016011333A (es) Sistemas de administracion de farmaco y metodo para el tratamiento de cancer de vejiga con gemcitabina.
PH12019501971A1 (en) Intradialytic use of sodium thiosulfate
MX2015011905A (es) Uso de levocetirizina y montelukast en el tratamiento de la vasculitis.
MX2015012444A (es) Metodos de diagnostico, seleccion y tratamiento de enfermedades y afecciones provocadas por o asociadas con metanogenos.
ZA202208504B (en) Intradialytic use of sodium nitrite
NZ720273A (en) Preparations and methods for treating a gd2 positive cancer
MX2017015664A (es) Administracion intravenosa de citrulina durante cirugia.
MX2017009313A (es) Formulaciones intravenosas de baclofeno y metodos de tratamiento.
EA202091743A1 (ru) Вакцинация дендритными клетками параллельно с химиотерапией
PH12016501101A1 (en) Veliparib in combination with carboplatin for the treatment of triple negative breast cancer
RU2014106575A (ru) Способ профилактики кровотечения при миомэктомии
NZ725067A (en) Anti-tumor agent containing anti-tumor platinum complex, and anti-tumor effect enhancer
MX2020002730A (es) Metodos de preparacion de composiciones que contienen timoquinona.
UA121529U (uk) Спосіб профілактики приглухуватості у хворих на ексудативний середній отит